Di Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Di Zhou has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Aizong Shen
Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, Hefei, Anhui, China; Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
1 shared publication Huijuan Qu
Department of Phase I Clinical Trials Laboratory, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China; Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, Hefei, Anhui, China
1 shared publicationJie He
Hefei Lifeon Pharmaceutical Co., Ltd., Hefei, Anhui, China
1 shared publicationJun Chen
Hefei Lifeon Pharmaceutical Co., Ltd., Hefei, Anhui, China
1 shared publicationLiang Li
Department of Cancer Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publicationLijuan Ning
Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy, Hefei, Anhui, China; Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China
1 shared publication
Latest Publications
- 27 April 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (9) , 104299
Pharmacokinetics and safety study of methylphenidate hydrochloride sustained-release tablets in Chinese healthy participants
- 27 April 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (9) , 104299
Pharmacokinetics and safety study of methylphenidate hydrochloride sustained-release tablets in Chinese healthy participants
- Open Access
- 29 December 2025
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (1) , 102818
Therapeutic potential of ISG20 in attenuating podocyte injury via inhibition of ferroptosis
- 29 December 2025
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 37 (1) , 102818
Open AccessTherapeutic potential of ISG20 in attenuating podocyte injury via inhibition of ferroptosis